• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ambrisentan Teva
    / Abic


    Active Ingredient
    Ambrisentan 5 mg, 10 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    5 mg, 10 mg

    not in the basket chart

    Related information


    Dosage

    Monotherapy: 5 mg once daily and may be increased to 10 mg daily depending upon clinical response and tolerability.
    In combination with tadalafil: titrate up to 10 mg once daily.  


    Indications

    Treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment with tadalafil. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.


    Contra-Indications

    Please refer to the license holder for further details.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Important notes

    Please refer to the license holder for further details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE